🇺🇸 FDA
Patent

US 10151756

Predictive markers for polyamine inhibitor cancer therapies

granted A61KA61K31/192A61K31/196

Quick answer

US patent 10151756 (Predictive markers for polyamine inhibitor cancer therapies) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/192, A61K31/196, A61K31/198, A61K31/616